Some drug manufacturing companies paid a strikingly low compensation of Rs50,000 for a life lost during their clinical trials last year, government data has suggested.

While the average cost of each

Global drugmakers could face new U.S. scrutiny after a report from lawmakers in India alleged abuses in that country's drug approval process, lawyers familiar with such investigations said.

A parliam